Xing Z - Search Results

1

Murine airway luminal antituberculosis memory CD8 T cells by mucosal immunization are maintained via antigen-driven in situ proliferation, independent of peripheral T cell recruitment.

Jeyanathan M, Mu J, McCormick S, Damjanovic D, Small CL, Shaler CR, Kugathasan K, Xing Z. Jeyanathan M, et al. Among authors: xing z. Am J Respir Crit Care Med. 2010 Apr 15;181(8):862-72. doi: 10.1164/rccm.200910-1583OC. Epub 2009 Dec 17. Am J Respir Crit Care Med. 2010. PMID: 20019338

2

Enhanced immunogenicity of BCG vaccine by using a viral-based GM-CSF transgene adjuvant formulation.

Wang J, Zganiacz A, Xing Z. Wang J, et al. Among authors: xing z. Vaccine. 2002 Jul 26;20(23-24):2887-98. doi: 10.1016/s0264-410x(02)00241-4. Vaccine. 2002. PMID: 12126899

3

Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis.

Chen L, Wang J, Zganiacz A, Xing Z. Chen L, et al. Among authors: xing z. Infect Immun. 2004 Jan;72(1):238-46. doi: 10.1128/IAI.72.1.238-246.2004. Infect Immun. 2004. PMID: 14688101 Free PMC article.

4

Activation of CD8 T cells by mycobacterial vaccination protects against pulmonary tuberculosis in the absence of CD4 T cells.

Wang J, Santosuosso M, Ngai P, Zganiacz A, Xing Z. Wang J, et al. Among authors: xing z. J Immunol. 2004 Oct 1;173(7):4590-7. doi: 10.4049/jimmunol.173.7.4590. J Immunol. 2004. PMID: 15383593

5

Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis.

Wang J, Thorson L, Stokes RW, Santosuosso M, Huygen K, Zganiacz A, Hitt M, Xing Z. Wang J, et al. Among authors: xing z. J Immunol. 2004 Nov 15;173(10):6357-65. doi: 10.4049/jimmunol.173.10.6357. J Immunol. 2004. PMID: 15528375

6

Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen.

Santosuosso M, Zhang X, McCormick S, Wang J, Hitt M, Xing Z. Santosuosso M, et al. Among authors: xing z. J Immunol. 2005 Jun 15;174(12):7986-94. doi: 10.4049/jimmunol.174.12.7986. J Immunol. 2005. PMID: 15944305

7

Adenoviral vectors for mucosal vaccination against infectious diseases.

Santosuosso M, McCormick S, Xing Z. Santosuosso M, et al. Among authors: xing z. Viral Immunol. 2005;18(2):283-91. doi: 10.1089/vim.2005.18.283. Viral Immunol. 2005. PMID: 16035940 Review.

8

Recent advances in the development of adenovirus- and poxvirus-vectored tuberculosis vaccines.

Xing Z, Santosuosso M, McCormick S, Yang TC, Millar J, Hitt M, Wan Y, Bramson J, Vordermeier HM. Xing Z, et al. Curr Gene Ther. 2005 Oct;5(5):485-92. doi: 10.2174/156652305774329230. Curr Gene Ther. 2005. PMID: 16250889 Review.

9

Development of cell-based tuberculosis vaccines: genetically modified dendritic cell vaccine is a much more potent activator of CD4 and CD8 T cells than peptide- or protein-loaded counterparts.

Malowany JI, McCormick S, Santosuosso M, Zhang X, Aoki N, Ngai P, Wang J, Leitch J, Bramson J, Wan Y, Xing Z. Malowany JI, et al. Among authors: xing z. Mol Ther. 2006 Apr;13(4):766-75. doi: 10.1016/j.ymthe.2005.10.018. Epub 2005 Dec 15. Mol Ther. 2006. PMID: 16343993 Free article.

10

Use of recombinant virus-vectored tuberculosis vaccines for respiratory mucosal immunization.

Xing Z, Lichty BD. Xing Z, et al. Tuberculosis (Edinb). 2006 May-Jul;86(3-4):211-7. doi: 10.1016/j.tube.2006.01.017. Epub 2006 Feb 28. Tuberculosis (Edinb). 2006. PMID: 16504584 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,663 results

Search Page

Filters